Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06449547

Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia

Risk Factors Analysis of Anxiety and Depression in Patients With Herpes Zoster Neuralgia and Characteristics of Serum Biomarkers and Functional Brain Magnetic Resonance Changes

Status
Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to explore risk factors of anxiety and depression in patients with herpes zoster neuralgia, and the changes of certain serum biomarkers and functional brain magnetic resonance images of these patients.

Detailed description

Patients with herpes zoster neuralgia will be recruited and take Hospital anxiety depression rating scale (Hospital anxiety and 'scale, HADS) evaluation. According to the HADS Scores, patients will be divided into depression group and no depression, or anxiety group and no anxiety group. The clinical data the of two groups will be collected and statistically analyzed to explore the risk factors of anxiety and depression, including the changes of serum biomarkers and functional brain magnetic resonance imaging in patients with herpes zoster neuralgia accompanying anxiety or depression.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHospital Anxiety and Depression ScaleHospital Anxiety and Depression Scale questionnaire is used to test patients for anxiety and depression.

Timeline

Start date
2024-06-21
Primary completion
2026-05-01
Completion
2026-12-01
First posted
2024-06-10
Last updated
2024-08-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06449547. Inclusion in this directory is not an endorsement.